IL6 and ST Elevation Myocardial Infarction: Higher IL-6 levels, particularly following ST-elevation myocardial infarction (STEMI), are linked to larger infarct sizes and reduced cardiac function, making IL-6 a potential biomarker for STEMI prognosis.